Bionano Genomics Inc (NASDAQ:BNGO)
| 1.68 Delayed Data As of May 20 |  -0.005 / -0.30%Today’s Change | 1.16 Today|||52-Week Range 9.12 | -43.98% Year-to-Date |
Latest BNGO News | Press Releases
| 3 Stocks to Short in May, Despite the Recent Market Sell-Off May 16 / StockNews.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.68 |
| Today’s open | 1.72 |
| Day’s range | 1.57 - 1.77 |
| Volume | 253,441 |
| Average volume (3 months) | 7,716,300 |
| Market cap | $486.7M |
Data as of 4:04pm ET, 05/20/2022
Growth & Valuation
| Earnings growth (last year) | +33.63% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +111.47% |
| P/E ratio | NM |
| Price/Sales | 46.03 |
| Price/Book | 1.44 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ATRAAtara Biotherapeutic... | +0.02 | +0.39% |
| OCGNOcugen Inc | 0.00 | 0.00% |
| VXRTVaxart Inc | +0.21 | +5.82% |
| GERNGeron Corp | +0.01 | +1.14% |
Data as of 4:04pm ET, 05/20/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $18.0M |
| Annual profit (last year) | -$72.4M |
| Net profit margin | -402.84% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
